LMT328, a sulfiredoxin inhibitor, induces preferential cancer cell death and tumor regression via oxidative stress.
- DOI
- 10.1016/j.freeradbiomed.2026.04.157
- Published
- 2026 Aug 1
- Container
- Free radical biology & medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.freeradbiomed.2026.04.157,
title = {LMT328, a sulfiredoxin inhibitor, induces preferential cancer cell death and tumor regression via oxidative stress.},
author = {Lee GR and Kwon M and Kim T and Chang H and Jang Y and Oh SH and Choi Y and Lee JS and Jeong W},
year = {2026},
journal = {Free radical biology \& medicine},
doi = {10.1016/j.freeradbiomed.2026.04.157},
url = {https://doi.org/10.1016/j.freeradbiomed.2026.04.157}
}RIS
TY - JOUR TI - LMT328, a sulfiredoxin inhibitor, induces preferential cancer cell death and tumor regression via oxidative stress. AU - Lee GR AU - Kwon M AU - Kim T AU - Chang H AU - Jang Y AU - Oh SH AU - Choi Y AU - Lee JS AU - Jeong W PY - 2026 JO - Free radical biology & medicine DO - 10.1016/j.freeradbiomed.2026.04.157 UR - https://doi.org/10.1016/j.freeradbiomed.2026.04.157 ER -
APA
GR, L., M, K., T, K., H, C., Y, J., SH, O., Y, C., JS, L., & W, J. (2026). LMT328, a sulfiredoxin inhibitor, induces preferential cancer cell death and tumor regression via oxidative stress.. Free radical biology & medicine. https://doi.org/10.1016/j.freeradbiomed.2026.04.157
Source records
- pubmed · retrieved 2026-09-26T20:06:49.814Z